Physician profile
Andra Walker
NPI 1508041211
$1,736.83
in general payments reported to CMS, 2019-2025
21 companies · $702 in 2025
The $702 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $187 · 2024: $848 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,736.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $273.78 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $255.63 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $228.46 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $175.26 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Astellas Pharma US INC | $144.94 | 2023-2025 | Veozah |
| Noven Therapeutics, LLC | $99.59 | 2024 | Xelstrym |
| Pfizer INC. | $91.95 | 2024-2025 | |
| Dexcom, INC. | $88.10 | 2024-2025 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $73.57 | 2024 | Dupixent |
| Amgen INC. | $64.38 | 2024-2025 | Evenity, Repatha, Otezla |
| Medtronic, INC. | $35.43 | 2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $30.86 | 2025 | Watchman Flx |
| Glaxosmithkline, LLC. | $30.75 | 2025 | Arexvy, Shingrix, Bexsero |
| Exact Sciences Corporation | $26.48 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $22.42 | 2025 | Freestyle Libre 3 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $18.73 | 2023 | Rexulti |
| Agile Therapeutics, INC. | $18.09 | 2024 | Twirla |
| Phathom Pharmaceuticals, INC. | $15.55 | 2024 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.20 | 2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.13 | 2024 | Xifaxan |
| Tonix Medicines, INC. | $13.53 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andra Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.